IRIS
VITALE, Carmine
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.226
EU - Europa 4.755
AS - Asia 1.647
Continente sconosciuto - Info sul continente non disponibili 39
AF - Africa 4
SA - Sud America 4
OC - Oceania 3
Totale 20.678
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.214
UA - Ucraina 1.522
CN - Cina 831
VN - Vietnam 776
GB - Regno Unito 703
SE - Svezia 667
DE - Germania 539
IT - Italia 514
FR - Francia 457
FI - Finlandia 137
NL - Olanda 62
EU - Europa 39
PL - Polonia 36
RU - Federazione Russa 25
IE - Irlanda 24
BE - Belgio 18
IN - India 14
CA - Canada 10
AT - Austria 9
JP - Giappone 7
ES - Italia 5
GR - Grecia 5
BG - Bulgaria 4
CH - Svizzera 4
DK - Danimarca 4
LU - Lussemburgo 4
CZ - Repubblica Ceca 3
IR - Iran 3
KR - Corea 3
RS - Serbia 3
SG - Singapore 3
AU - Australia 2
BO - Bolivia 2
HR - Croazia 2
MX - Messico 2
PT - Portogallo 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
TR - Turchia 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BT - Bhutan 1
CY - Cipro 1
DZ - Algeria 1
GH - Ghana 1
JO - Giordania 1
KZ - Kazakistan 1
LT - Lituania 1
MA - Marocco 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
TW - Taiwan 1
UY - Uruguay 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 20.678
Salva come PNG Salva come JPEG
Città #
Fairfield 2.107
Woodbridge 1.882
Houston 1.678
Ann Arbor 1.318
Wilmington 1.050
Ashburn 911
Chandler 897
Seattle 840
Dong Ket 774
Cambridge 688
Dearborn 535
Nyköping 441
Jacksonville 426
Shenzhen 394
Southend 392
Beijing 187
Lawrence 152
Princeton 151
Ogden 108
Boardman 105
New York 91
San Diego 73
Grafing 69
Norwalk 63
Des Moines 49
Groningen 49
London 46
Düsseldorf 43
Falls Church 39
Nanjing 35
Kraków 34
Jinan 31
Naples 24
Dublin 23
Bergamo 22
Shenyang 21
Hefei 19
Napoli 19
Nanchang 18
Brussels 17
Edinburgh 17
Auburn Hills 15
Redwood City 15
Bremen 14
Rome 14
Kunming 13
Washington 13
Kilburn 12
Milan 12
Florence 11
Helsinki 10
New Bedfont 10
Tappahannock 9
Vienna 9
Changsha 8
Hangzhou 8
Hebei 8
Matawan 8
Ningbo 8
Nürnberg 8
Wandsworth 8
Chicago 7
Chiswick 7
Haikou 7
Hounslow 7
Lanzhou 7
Amsterdam 6
Catania 6
Tianjin 6
Zhengzhou 6
Acton 5
Boston 5
Greenville 5
Los Angeles 5
St Louis 5
Stockholm 5
Atlanta 4
Baotou 4
Caserta 4
Castellammare Di Stabia 4
Copenhagen 4
Frankfurt am Main 4
Guangzhou 4
Hanover 4
Philadelphia 4
Redmond 4
Sacramento 4
Sofia 4
Taizhou 4
Agia Paraskevi 3
Aversa 3
Belgrade 3
Bologna 3
Chengdu 3
Fuzhou 3
Indiana 3
Jiaxing 3
Lappeenranta 3
Las Vegas 3
Luxembourg 3
Totale 16.225
Salva come PNG Salva come JPEG
Nome #
Progressive parkinsonism, balance difficulties, and supranuclear gaze palsy 556
Compulsive drumming induced by dopamine agonists in Parkinson's disease: Another aspect of punding. 233
Effect of Global Postural Rehabilitation program on spatiotemporal gait parameters of parkinsonian patients: a three-dimensional motion analysis study. 226
Validation of an Italian version of the 40-item University of Pennsylvania Smell Identification Test that is physician administered: our experience on one hundred and thirty-eight healthy subjects 213
Common mutations in the LRRK2 exon 41 are not responsible for essential tremor in Italian patients 212
Cognitive and affective theory of mind in patients with essential tremor 207
DRD3 Ser9Gly variant is not associated with essential tremor in a series of Italian patients 200
Reliability and validity of Italian version of the Dimensional Apathy Scale in Parkinson’s Disease 200
Caffeine consumption and the 4-year progression of de novo Parkinson's disease 200
Hearing Impairment in Parkinson’s Disease: Expanding the Non-Motor Phenotype 196
Effects of Global Postural Reeducation on gait kinematics in parkinsonian patients: a pilot randomized three-dimensional motion analysis study 196
Differential neuropsychological profiles in Parkinsonian patients with or without vascular lesions 193
Apathy in untreated, de novo patients with Parkinson's disease: validation study of Apathy Evaluation Scale 192
Pisa syndrome in Parkinson's disease and parkinsonism: clinical features, pathophysiology, and treatment 191
Gender differences in non-motor symptoms in early, drug naïve Parkinson's disease 188
Non-motor symptoms in early Parkinson’s disease: a 2-year follow-up study on previously untreated patients 187
Side of onset does not influence cognition in newly diagnosed untreated Parkinson's disease patients 186
Relationship between depression and cognitive dysfunctions in Parkinson’s disease without dementia 184
The heterogeneity of early Parkinson's disease: a cluster analysis on newly diagnosed untreated patients 179
Insulin-like growth factor-1 and progression of motor symptoms in early, drug-naïve Parkinson's disease 179
Resting-state functional connectivity associated with mild cognitive impairment in Parkinson's disease 179
Nonmotor predictors for levodopa requirement in de novo patients with Parkinson's disease 178
Abnormal eating behaviors in progressive supranuclear palsy 177
Apathy and related Executive Syndromes in Dementia associated with Parkinson’s Disease and in Alzheimer’s Disease 177
How does smoking affect olfaction in Parkinson's disease? 175
Subthreshold depression and subjective cognitive complaints in Parkinson's disease 173
Diagnosis and treatment of restless legs syndrome in progressive supranuclear palsy 168
Apathy in Parkinson’s Disease: diagnosis, neuropsychological correlates, pathophysiology and treatment 167
Teaching NeuroImages: pseudo-abnormal DaTscan findings in meningioma-induced parkinsonism 165
Is serum uric acid related to non-motor symptoms in de-novo Parkinson's disease patients? 165
The role of embodied simulation in mental transformation of whole-body images: evidence from Parkinson's disease 165
Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson's disease patients. 164
Pathological gambling in Parkinson's disease. A comprehensive review 163
Gender and non motor fluctuations in Parkinson's disease: a prospective study 163
Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study 162
Segmental progression of cardinal motor symptoms in Parkinson's disease: a pilot study suggesting a practical approach to rate disease course in the early stages 162
Affective theory of mind in patients with Parkinson's disease: comment 162
Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease 161
Do subjective memory complaints herald the onset of mild cognitive impairment in Parkinson disease? 161
Gender differences in non-motor symptoms in early Parkinson's disease: a 2-years follow-up study on previously untreated patients 160
Cognitive dysfunctions in occipital lobe epilepsy compared to temporal lobe epilepsy. 160
Clinical clusters and dopaminergic dysfunction in de-novo Parkinson disease. 160
Hypomorphic NOTCH3 mutation in an Italian family with CADASIL features 159
Functional involvement of central cholinergic circuits and visual hallucinations in Parkinson's disease 159
Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients 158
Vestibular impairment and adaptive postural imbalance in parkinsonian patients with lateral trunk flexion 158
Gait Patterns in Parkinsonian Patients With or Without Mild Cognitive Impairment 157
Electrophysiological comparison between males and females in HNPP 156
Neuropsychological profile of adult patients with non symptomatic occipital lobe epilepsies 156
Normative data for the Montreal Cognitive Assessment in an Italian population sample 156
Effects of physical rehabilitation on gait pattern in parkinsonian patients with lateral trunk flexion: a three dimensional motion analysis investigation 155
A neuropsychological longitudinal study in Parkinson's patients with and without hallucinations 155
Cervico-oculo-Acoustic syndrome in a male with consanguineous parents 155
The use of University of Pennsylvania Smell Identification Test in the diagnosis of Parkinson's disease in Italy 155
Resting-state brain connectivity in patients with Parkinson’s disease and freezing of gait 154
Four-Year Longitudinal Study on Restless Legs Syndrome in Parkinson Disease. 154
Impact of cognitive tasks on kinematic gait parameters in FTD patients 151
Parkinson’s patients with or without MCI classified according to wavelet analysis of lower limb joint angles in gait cycle 151
Impulse control disorders and cognitive dysfunctions in patients with Parkinson's disease 151
The "eye of the tiger" sign in pure akinesia with gait freezing 150
Hemi-Restless Legs Syndrome induced by Clebopride 150
Bilirubin and Uric Acid: Two Different Anti-oxidants in Parkinson's Disease 150
Season of birth and Parkinson's disease: possible relationship? 148
Linkage exclusion in Italian families with hereditary essential tremor 147
Gender and non motor fluctuations in Parkinson's disease: A prospective study 147
Simultaneous absence of dopamine D1 and D2 receptor-mediated signaling is lethal in mice 146
Uric acid relates to dopamine transporter availability in Parkinson's disease 146
Cortical thickness changes in patients with Parkinson's disease and impulse control disorders. 146
The closing-in phenomenon in Parkinson's disease 146
Early MRI findings in Acquired hepatocerebral degeneration 145
Anxiety in early Parkinson's disease: Validation of the Italian observer-rated version of the Parkinson Anxiety Scale (OR-PAS) 145
Comment on Poletti et al. “Affective theory of mind in patients with Parkinson's disease”. 144
Apoptotic mechanisms in mutant LRRK2-mediated cell death 144
Cerebellar and pyramidal dysfunctions, palpebral ptosis and weakness as presenting symptoms of PARK-2 143
Dopamine transporter availability in motor subtypes of de novo drug-naïve Parkinson's disease 141
Assessment of apathy minimising the effect of motor dysfunctions in Parkinson’s disease: a validation study of the dimensional apathy scale 141
Comparative neuropsychological profile of pathological gambling, hypersexuality, and compulsive eating in Parkinson's disease 139
Link between non-motor symptoms and cognitive dysfunctions in de-novo, drug naïve PD patients 139
Unawareness of dyskinesias in Parkinson's and Huntington's diseases 139
Impulse Control Disorders induced by Rasagiline as adjunctive therapy for Parkinson's disease: Report of 2 Cases 138
Neuropsychological correlates of Pisa syndrome in patients with Parkinson's disease 138
No evidence of association between CAG expansions and essential tremor in a large cohort of Italian patients 137
Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients 137
The non-motor side of the honeymoon period of Parkinson's disease and its relationship with quality of life: a 4-year longitudinal study 137
Cortical thickness in Parkinsonians with impulse control disorders: A comment 137
Cognitive Dysfunctions and Pathological Gambling in Patients with Parkinson’s Disease 135
Lower serum uric acid is associated with mild cognitive impairment in early Parkinson's disease: a 4-year follow-up study. 135
The relationship between cerebral vascular disease and parkinsonism: the VADO study 134
Extended release levodopa at bedtime as a treatment for nocturiain Parkinson's disease: An open label study 130
Pallidal stimulation in atypical pantothenate kinase-associated neurodegeneration: six-year follow-up 129
Mild Cognitive Impairment in drug-naïve PD patients is associated with cerebral hypometabolism 128
A metabolomic signature of treated and drug-naïve patients with Parkinson’s disease: a pilot study 128
The role of Vitamin D levels on neuropsychological profile of patients with Parkinson’s Disease 127
Hearing impairment in Parkinson’s disease: expanding non motor phenotype 126
Quitting smoking: an early non-motor feature of Parkinson's disease? 126
Impact of anxiety, apathy and reduced functional autonomy on perceived quality of life in Parkinson's disease 125
Ping-pong gaze: Sherrington would not have done it better 124
Anxiety and cognition are associated with dopaminergic dysfunction in de novo Parkinson’s disease 121
Short-term continuous infusion of apomorphine hydrochloride for treatment of Huntington's chorea: A double blind, randomized cross-over trial 119
Reply to Zappia et al.'s comment on personality and Parkinson's Disease: A meta-analysis 119
Totale 16.251
Salva come PNG Salva come JPEG
Categoria #
all - tutte 66.116
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.116
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.208 0 0 0 0 0 0 0 0 0 250 522 436
2019/20206.015 388 484 524 1.449 612 537 715 385 488 107 279 47
2020/20213.202 267 88 336 187 426 105 337 39 148 241 136 892
2021/20221.528 189 151 44 402 84 102 163 120 98 95 50 30
2022/20232.611 310 164 143 315 236 436 106 312 312 75 150 52
2023/20241.069 91 44 449 46 26 106 32 81 171 23 0 0
Totale 20.966